相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- ChemE Show 2026 opens June 9-10 in Houston, bringing together pharmaceutical and petrochemical industry leaders including Eli Lilly and Johnson & Johnson to address manufacturing convergence. - The inaugural event focuses on decarbonization, digital transformation, and AI applications in chemical manufacturing, with over 100 exhibitors showcasing process technologies. - Senior leaders from major pharmaceutical companies will present on topics including biopharma manufacturing, circular chemistry, and bio-based materials development. - The conference addresses critical industry challenges that span sector boundaries, emphasizing the intersection of pharmaceutical R&D and chemical engineering innovations.
- Honeywell announced the acquisition of Johnson Matthey's Catalyst Technologies business for £1.8 billion in an all-cash transaction, representing approximately 11x estimated 2025 EBITDA. - The acquisition expands Honeywell's catalyst and process technology offerings, enabling comprehensive solutions for producing lower-emission fuels including sustainable aviation fuel, blue hydrogen, and blue ammonia. - Johnson Matthey's Catalyst Technologies business employs approximately 1,900 people and operates as a leading provider of catalyst manufacturing and process technology licensing with sites across the US, Europe, and India. - The transaction is expected to close by the first half of 2026, subject to regulatory approvals, and will be accretive to earnings in the first year while adding high growth vectors to Honeywell's Energy and Sustainability Solutions segment.
